title: Adding pancreatic panniculitis to the panel of skin lesions associated with triple therapy of chronic hepatitis C.
authors: Nubio
authors: N
authors: Pfaundler
authors: Kerstin
authors: K
authors: Kessebohm
authors: Roland
authors: R
authors: Blum
authors: Marco
authors: M
authors: Stieger
authors: Felix
authors: F
authors: Stickel
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D001706:Biopsy; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008103:Liver Cirrhosis / Q000821:virology; D008875:Middle Aged; D009842:Oligopeptides / Q000009:adverse effects*; D010195:Pancreatitis / Q000139:chemically induced* / Q000473:pathology; D015434:Panniculitis / Q000139:chemically induced* / Q000473:pathology; D012254:Ribavirin / Q000009:adverse effects*; D012867:Skin / Q000473:pathology
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D009842:Oligopeptides; D012254:Ribavirin; C486464:telaprevir